학술논문

Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial
Document Type
Journal
Source
LANCET NEUROLOGY; JUL 2023, 22 7, p568-p577, 10p.
Subject
Language
English
ISSN
14744465